Sirenas Marine Discovery, LLC. logo

Sirenas Marine Discovery, LLC.

Marine Inspiration for New Therapeutics Sirenas Marine Discovery is dedicated to the discovery, chemical tailoring and early stage development of marine bioactive metabolites, with two potential first in-class programs in HIV and Oncology.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://sirenasmd.com
Founded2011
Disease Focus
Development Stage
STOCK CODENon Listed
Address
3550 General Atomics Court. Suite 02/211, CA, 92121
San Diego
United States
Email
Contact Number
+1 858-909-5685

Sirenas Marine Discovery is dedicated to the discovery, chemical tailoring and early stage development of marine bioactive metabolites, with two potential first in-class programs in HIV and Oncology.

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/sirenas-marine-discovery” connections=”true” suffix=””]

Its proprietary ADC technology is focused on rapid, informatics-driven discovery and generation of cytotoxic payloads with differentiated mechanisms and cancer cell killing profiles.

In Feb 2018, Sirenas entered into a multi-target research agreement with Bristol-Myers Squibb to deploy Sirenas drug discovery platform to identify potential drug candidates against undisclosed therapeutic targets. Under the terms, Sirenas will receive an undisclosed up-front payment, funding for research activities and potential success fees from BMS. In addition, BMS, has an option to license compounds identified from the collaborative efforts under a separate agreement that will include potential milestones and royalties paid to Sirenas.

In Dec 2017, Sirenas received research grant totaling $1.68 Mn from Bill & Melinda Gates Foundation to accelerate its drug discovery technology, ATLANTISŽ.